Entrada Therapeutics Inc (TRDA)

Entrada Therapeutics Inc Stock Forecast & Price Targets

See the Price Targets and Ratings of:

Analyst Rating Consensus

Moderate Buy
Based on 3 analysts giving stock ratings to
Therapeutics Inc
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

Analyst Price Target on TRDA

Average Price Target

▲(258.47% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Entrada Therapeutics Inc in the last 3 months. The average price target is $29.00 with a high forecast of $29.00 and a low forecast of $29.00. The average price target represents a 258.47% change from the last price of $8.09.
Highest Price Target$29.00Average Price Target$29.00Lowest Price Target$29.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Upside / Downside
Upgrade Banner
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PRVAPrivia Health Group
DBTXDecibel Therapeutics
ABCLAbCellera Biologics
CMPXCompass Therapeutics
TSHATaysha Gene Therapies
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis